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Inferring Genetic Ancestry:
Opportunities, Challenges, and Implications
Charmaine D. Royal,1,* John Novembre,2 Stephanie M. Fullerton,3 David B. Goldstein,1
Jeffrey C. Long,4 Michael J. Bamshad,5 and Andrew G. Clark6
Increasing public interest in direct-to-consumer (DTC) genetic ancestry testing has been accompanied by growing concern about issues
ranging from the personal and societal implications of the testing to the scientiﬁc validity of ancestry inference. The very concept of
‘‘ancestry’’ is subject to misunderstanding in both the general and scientiﬁc communities. What do we mean by ancestry? How exactly
is ancestry measured? How far back can such ancestry be deﬁned and by which genetic tools? How do we validate inferences about
ancestry in genetic research? What are the data that demonstrate our ability to do this correctly? What can we say and what can we
not say from our research ﬁndings and the test results that we generate? This white paper from the American Society of Human Genetics
(ASHG) Ancestry and Ancestry Testing Task Force builds upon the 2008 ASHG Ancestry Testing Summary Statement in providing a more
in-depth analysis of key scientiﬁc and non-scientiﬁc aspects of genetic ancestry inference in academia and industry. It culminates with
recommendations for advancing the current debate and facilitating the development of scientiﬁcally based, ethically sound, and socially
attentive guidelines concerning the use of these continually evolving technologies.Introduction
In recent years, advances in genetics
and genomics have brought new
dimensions to the commercial genetics
enterprise in the form of DTC genetic
testing. With the click of a mouse, the
publicnowhasdirect access topersonal
genetic and genomic information
related to health, ancestry, nutrition,
physical traits, athletic ability, dating
compatibility, and a seemingly inﬁnite
list of other attributes. Although
health-related DTC genetic testing
appropriately continues to receive a
substantial amount of attention,1,2
discourse regarding other DTC applica-
tions of genetics, in particular the
echoing of concern about genetic
ancestry testing, is increasing.3–6 There
are approximately 40 companies,
based in various countries, that
currently provide genetic ancestry
testing to the public (Table 1). The
companies differ in both the range of
genetic testing services and the types
of ancestry tests that they offer.
The marketing of genetic tests di-
rectly to consumers is a priority area
for the ASHG, as demonstrated by its
statements on DTC health-related
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ASHG, expands discussion of the
issues highlighted in the Society’s
2008 Ancestry Testing Summary
Statement8 and introduces additional
pertinent issues. The purpose of our
report is twofold: (1) to enlighten
and engage ASHG members and the
broader scientiﬁc and general com-
munities and (2) to assist in deter-
mining the appropriate course of
action for the Society in responding
to the critical concerns.
It is important to note that the
genetic tools employed by ancestry
testing companies, as well as many
of the scientists involved in DTC
ancestry testing, have their roots in,
and are still a part of, academia. There-
fore, in this report, as in the summary
statement, we evaluate application of
ancestry estimation technologies in
both environments because the many
overlapping scientiﬁc and nonscien-
tiﬁc issues in academic research have
not, to date, been adequately ad-
dressed.
Deﬁnition(s) of Ancestry
Our common origin as a species
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The American Journal of Humanrelated to one another by varying
degrees,9 so it is important to be clear
about what frame of reference is being
used in discussions of ‘‘ancestry’’ and
relationship (Figure 1). For example,
because of recombination, each seg-
ment of the genomehas its own ances-
tral history, and various segments of
an individual’s genome may have an-
cestral histories that trace to different
populations.
One commonly employed concept
of ancestry is continental ancestry,
which assumes the existence of four
or ﬁve major ‘‘parental’’ populations
that gave rise within the last 100,000
years to existing populations.10 This
conception of ancestry is frequently
equated with that of ‘‘race,’’ and
the terms are often used interchange-
ably; however, this is problematic
because in the history of science
there have been many ‘‘racial’’ taxo-
nomic schemes.11,12 A related view
of ancestry is biogeographic ancestry,
in which a person’s origin is associ-
ated with the geographic location(s)
of presumed ancestors inferred by
comparison with contemporary pop-
ulations living in these locations.13,14
There is also lineage or family history,logy and Evolutionary Biology, University of Cal-
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Table 1. Companies Providing Direct-to-Consumer Genetic Ancestry Testing
Companya URL
Start Date,
Locationb Genetic Testing Services Ancestry Tests Offered
1. African Ancestry http://www.africanancestry.com/ 2002 Ancestry mtDNA, Y chromosome
2. African DNA http://www.africandna.com/ 2007 Ancestry mtDNA, Y
3. Ancestry.com http://ancestry.com 2007 Ancestry mtDNA, Y
4. Ancestry by DNA http://ancestrybydna.com 2009 Ancestry mtDNA, Y, admixture
5. ARGUS Biosciences http://www.argusbio.com/ 2003 Ancestry, cancer tissue screening,
personal DNA sequencing
mtDNA-HV, mtDNA-FL, Y
6. Cambridge DNA
Services
http://www.cambridgedna.com/ 2007
UK
Ancestry mtDNA, Y, admixture
7. deCODEme http://www.decodeme.com/ 2007
Iceland
R&D, complete scan, cancer scan,
cardio scan
mtDNA, Y, map of kinship,
genetic atlas
8. Determigene http://www.determigene.com/ 2002 Paternity, immigration DNA
testing, inﬁdelity testing,
twin zygosity, ancestry,
DNA safeguarding
Ancestral origins DNA ancestry
map (population matches,
native region matches,
strength indicators)
9. DNA Ancestry http://www.easternbiotech.com 2006
Dubai, UAE
Ancestry mtDNA, Y
10. DNA Direct http://www.dnadirect.com/web/ 2003 Screening tests, genetic disorders,
drug response, DNA storage,
paternity and family tests
Y
11. DNA Identity
Testing Center
http://www.800dnaexam.com/ 2006 Paternity, family relationship
DNA tests, immigration, adoption,
forensic, ancestry, identity
mtDNA, Y
12. DNA Heritage http://www.dnaheritage.com/ 2003
UK
Ancestry mtDNA, Y, surname projects
13. DNA Reference
Laboratory
http://www.dnareferencelab.com 2006 Paternity, immigration paternity
testing, ancestry, forensic,
infectious-disease testing, R&D
mtDNA, Y, ethnicity DNA
makeup, European ancestry
DNA test, Native American
ethnicity DNA test
14. DNA Solutions http://www.dnasolutions.us/ 2000 R&D, paternity, sibling DNA,
grandparent, twins test,
ancestry, bird sexing
mtDNA, Y
15. DNA Testing Systems http://dnaconsultants.com/ 2003 Ancestry, paternity, linkage
disequilibrium
mtDNA, Y, admixture, Native
American, African, Melungeon
test, Hindu single & double
for males
16. DNA Tribes http://www.dnatribes.com/ 2006 Ancestry Autosomal analysis
17. DNAWorldwide http://www.dna-worldwide.com/ 2005
UK
Paternity, relationship,
immigration, ancestry, forensic,
DNA storage, pet DNA
mtDNA, Y, world DNA match
18. easyDNA http://www.easy-dna.com/ 2006 Paternity, legal DNA test,
relationship, DNA proﬁles,
twin zygosity, forensic, ancestry,
immigration, maternity
Ancestral origins DNA ancestry
map (population matches,
native region matches, strength
indicators), mtDNA, Y
19. Ethno Ancestry http://www.ethnoancestry.com/ 2004
Scotland &
Ireland
Ancestry mtDNA, Y
20. Family Builder https://dna.familybuilder.com 2007 Ancestry mtDNA, Y
21. Family Genetics http://www.familygenetics.co.uk 2005
UK
Ancestry mtDNA, Y
22. Family Tree DNA http://www.familytreedna.com 2000 Ancestry mtDNA, Y, autosomal, X-STR
23. Genebase http://www.genebase.com/ 2005
Canada
Ancestry mtDNA, Y, autosomal DNA STR
24. Genelex http://www.healthanddna.com 2000 Paternity, drug sensitivity,
ancestry, predictive genetics
mtDNA, Y, Native American
DNA, Jewish DNA, African
ancestry DNA testing
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Table 1. Continued
Companya URL
Start Date,
Locationb Genetic Testing Services Ancestry Tests Offered
25. Genetic Testing
Laboratories, Inc.
http://www.gtldna.com/ 2002 Paternity, ancestry, inﬁdelity,
DNA maternity, siblingship,
twin zygosity, grandparentage,
missing parent, immigration,
prenatal
mtDNA, Y, ancestral origins
DNA ancestry map (population
matches, native region matches,
strength indicators)
26. Genetree http://www.genetree.com/ 2007 Ancestry mtDNA, Y
27. homeDNAdirect http://www.homednadirect.com/ 2006 Paternity, legal DNA testing,
relationship, forensic, ancestry
mtDNA, Y, ancestral origins
DNA ancestry map (population
matches, native region matches,
strength indicators)
28. International
Biosciences
http://www.ibdna.com 2007
UK
Paternity, ancestry, siblingship mtDNA, Y, ancestral origins
DNA ancestry map (population
matches, native region matches,
strength indicators)
29. Metaphase
Paternity Test
http://www.metaphasegenetics.
com/
2002 Paternity, siblingship,
grandparentage, twins, prenatal,
forensic, ancestry
Y
30. Oxford Ancestors http://www.oxfordancestors.com 2000
UK
Ancestry mtDNA, Y
31. Paternity Experts http://www.paternityexperts.com 2004 Paternity, sibling, ancestry,
forensic paternity
Admixture
32. Pathway Genomics http://www.pathway.com/ 2009 Health conditions, ancestry,
carrier status, personal traits,
monogenic dominants,
drug responses
mtDNA, Y
33. Roots for Real http://www.rootsforreal.com/ 2002
UK
Ancestry mtDNA, Y, admixture
34. Test Country http://www.testcountry.com 2001 Health conditions, substance
abuse, health & wellness,
pregnancy/fertility, early
disease detection, ancestry
Ancestral origins DNA ancestry
map (population matches,
native region matches,
strength indicators)
35. The Genographic
Project
https://genographic.
nationalgeographic.com/
2005 Research, ancestry mtDNA, Y
36. Universal Genetics;
DNA Testing Laboratory
http://www.dnatestingforpaternity.
com/
2009 Paternity, forensic, ancestry mtDNA, Y
37. Warrior Roots http://www.warriorroots.com/ 2009 Ancestry, linking ancestry
to ancient warrior groups,
athletic proﬁle
mtDNA, Y
38. 23andMe https://www.23andme.com/ 2006 Complete scan mtDNA, Y, global similarity
Last updated February 23, 2010.
a This list does not include companies or sites that only promote genetic ancestry testing services. On November 17, 2009 deCODE genetics (owner of
deCODEme) announced that it has filed a voluntary Chapter 11 bankruptcy petition but will continue to offer services during its restructuring process. On January
21, 2010, deCODE genetics was purchased by Saga Investments LLC, a consortium that includes Polaris Ventures and ARCH Venture Partners. Since the initial
preparation of this table, two companies have been removed from the list – DNA Ancestors has gone out of business, and DNA Diagnostics Center has become
a promoter site.
b Start date for offering genetic ancestry testing. Some companies were in existence prior to this date. Locations are listed for non-U.S. locations only.which typically represents a genera-
tional narrative about one’s relatives
through his or her maternal and
paternal lines of descent.15 It is this
notion of ancestry that people often
focus on when considering their gene-
alogy. However, we note that gene-
alogy does not necessarily confer
genetic similarity in all biological
systems; for example, even one’s
offspring may not be the ideal matchfor a kidney transplant or blood trans-
fusion.
In addition to the concepts
described above, there are sociopolit-
ical rules about ancestry that guide
membership in certain groups. In
the United States (US) these include
the legal and historic utility of hypo-
descent (‘‘one-drop’’ rule) for African
Americans and blood quantum laws
for Native Americans.16–18 In reality,The American Journal of Humanhowever, neither are these rules
absolute nor have they been consis-
tently applied.18 This further illus-
trates that ancestry-related social
identity—how a society may see or
deﬁne a person or group in relation-
ship to real or putative ancestry—is
to be distinguished from personal
or group interpretations of such
identity or actual knowledge of gene-
alogy.Genetics 86, 661–673, May 14, 2010 663
Figure 1. Global Ancestry
The arrows symbolize migration of early human ancestors out of Africa. The color mosaic denotes global population diversity resulting
from various subsequent inter- and intra-continental and regional migrations. The pedigree represents the complex network of interme-
diate and recent ancestors that is the subject of individual genetic genealogy testing.Interest in Ancestry Estimation
Consumers and researchers are inter-
ested in using genetic information to
infer ancestry for a variety of reasons,
including genealogical, anthropolog-
ical, and epidemiological. Most con-
sumers are interested in using
ancestry testing to gain, conﬁrm, or
extend knowledge about their recent
family genealogy.3,19 To permit infer-
ences about shared recent ancestry,
commercial testers of genetic ancestry
employ a variety of genetic-marker
systems to make comparisons be-
tween a customer’s DNA and genetic
databases of individuals sampled
from diverse populations and geo-
graphic regions. However, although
the concept of ‘‘ancestry’’ is least
ambiguous when it refers to either664 The American Journal of Human Geneticsvery close ancestors (i.e., parents or
grandparents) or our most distant
ancestors (i.e., the earliest hominids),
genetic ancestry tests typically address
more intermediate levels of ancestry
that are imprecisely deﬁned and
identiﬁed10,20 (Figure 1). Given this
intrinsic imprecision, the power of
commercial genetic tests to address
speciﬁc genealogical questions is
contingent on several factors that we
will discuss later in this paper.
Population geneticists and anthro-
pologists use genetic markers and
comparative datasets similar to those
used in commercial ancestry testing
to make inferences about population
histories and relationships. Ancestry
estimation has enormous value in
this regard because it has the potential86, 661–673, May 14, 2010to illuminate patterns of past human
migration and provide background
information about human genetic
variation that is essential for distin-
guishing the impact of demographic
processes from the effects of natural
selection.21–23 Unlike commercial
ancestry testing, such inferences are
nearly always made at the level of
populations or groups, rather than at
the individual level. As a consequence
of this plural focus, these ancestry
inferences are more robust with
respect to their fundamentally proba-
bilistic nature, and the limitations of
ancestry estimation for individuals
are comparatively less apparent.
Genetic epidemiologists with an
interest in identifying genetic associa-
tions with disease employ methods of
ancestry inference for speciﬁc analyt-
ical reasons: either to control for
statistical biases related to population
stratiﬁcation among cases and con-
trols24–26 or as a strategy to map
susceptibility variants that might be
differentially distributed with respect
to ancestry within groups whose his-
tories more clearly demonstrate the
‘‘mixing’’ of two or more peoples.
Recently admixed groups (such as
African Americans or Hispanic Ameri-
cans) provide the opportunity to per-
form mapping by admixture linkage
disequilibrium, commonly referred
to as admixture mapping.27–29 How-
ever, epidemiological inferences of
genetic ancestry are typically applied
to individuals and are nearly always
based on the analysis of large collec-
tions of single nucleotide polymor-
phisms (SNPs) or ancestry informative
markers (AIMs, described below). Each
individual’s genome is then mapped
as a mosaic of segments inferred to
be derived from one or the other
ancestral population (or both, in the
case where maternal and paternal
alleles in the individual are each
derived from different ancestral popu-
lations).
Human History and Variation
Genetic ancestry estimation is based
on an understanding of the distribu-
tion of diversity among human popu-
lations that reﬂects the demographic
and evolutionary history of our
species. Genetic and archaeological
evidence indicates that, over the past
100,000 years or so, as the population
size of humans increased markedly,
humans dispersed from East Africa to
populate other parts of the world30,31
(Figure 1). The number of migration
events, their magnitude, and the
routes that migrants took are still
active areas of research. Nevertheless,
it is apparent that the dispersal of
anatomically modern humans af-
fected the geographic distribution of
diversity in at least two important
ways. First, founder populations typi-
cally carried with them only a subset
of the genetic variation found in their
most immediate ancestral population
while simultaneously developingnew mutations and genetic proﬁles.
Second, as founder populations be-
came more widely separated from
one another, the probability that two
randomly chosen individuals would
mate with each other became even
lower, and matings were even more
likely to occur between people living
close to each other, accentuating the
divergence between geographically
isolated populations.
Over the past two decades, geneti-
cists have characterized the geo-
graphic pattern of variation in great
detail by using both haploid and
diploid genetic markers (described
below).32–37 Because different parts
of the genome can have different
ancestral histories, different marker
systems often provide somewhat dif-
ferent information about population
history and individual ancestry.
Currently, we only have partial
knowledge of how human genetic di-
versity is distributed across the globe,
but initial studies38 are revealing the
degree of resolution possible in testing
the relationship between genetic
ancestry and geographic origins.
A number of these studies have used a
collection of ~1100 DNA samples
obtained from 51 populations living
in different parts of the world; these
samples constitute the Human Ge-
netic Diversity Panel (HGDP).39 Anal-
ysis of 987 microsatellites typed in the
HGDP collection, for example, in-
ferred six population clusters that
correspond to continental regions
(i.e., Africa, America, Central/South
Asia, East Asia, and Oceania).38,40
Analysis of ~642,000 autosomal SNPs
in the HGDP collection enabled clus-
tering of individuals not only to these
large geographic regions, but also to
speciﬁc populations within these
regions.38,40 Although the HGDP
collection is a useful collection of
widely distributed human popula-
tions, it is a convenient sample and
does not sample densely within any
one geographic region; hence, there
are limitations to the accuracy of
ancestry inference within and among
regions. Several studies that sampled
populations deeply across Europe
have shown that population structureThe American Journal of Humancan be inferred even at ﬁne spatial
scales (i.e., the scale of several hun-
dreds of kilometers) within Eu-
rope.41–45 There is rapidly escalating
interest in ancestral histories of other
continents and geographic regions,
and the deeper timescales of popula-
tions from Africa46 and India47 have
identiﬁed deep splits among geo-
graphic regions with complex pat-
terns of past migration and admix-
ture. Further studies of human
genetic diversity are clearly needed;
these will determine whether such
ﬁne-scale geographic patterns can be
detected in other parts of the world
and assign interpretive values to these
patterns.
It is important to note that the
diversity of human social structures,
intermarriage patterns, and demo-
graphic histories makes it likely that
the resolution of population structure
will be challenging and that the
extent of the resolution will vary con-
siderably among populations. The
inclusion of individuals with recent
migration among ancestors creates
the more complex problem of disen-
tangling recently mixed ancestry.
Tools for Inferring Ancestry
Estimates of genetic ancestry are based
either on the use of haploid markers
(mitochondrial DNA [mtDNA] or Y
chromosome haplotypes) or on the
use of multiple unlinked autosomal
markers that are diploid and some-
times preselected to be ‘‘ancestry infor-
mative.’’ As uniparentally inherited
haploid markers, mtDNA provides
information about the female-to-
female transmitted lineage (male chil-
dren also inherit mtDNA from their
mothers but do not transmit it to their
offspring),whereas theY chromosome
is informative about male-to-male
transmitted lineage. More recently,
autosomal markers, which are inher-
ited from both parents, have been
used for assessing patterns of genetic
variation in worldwide human popu-
lations. Commercial genetic ancestry
testing primarily utilizes haploid
markers to make ancestry inferences
(Table 1), whereas estimates of ge-
netic ancestry in epidemiologicalGenetics 86, 661–673, May 14, 2010 665
applications rely almost exclusively on
the consideration of allele frequencies
of autosomal SNPs. Population geneti-
cists and anthropologists employ both
types of markers; which type they use
depends on the availability of funds
and the questions being addressed.
mtDNA and Y Chromosome Markers
Haploid genetic markers such as
mtDNA D-loop region sequences or
Y chromosome SNP haplotypes per-
mit direct comparison of the lineages
of sampled and reference individ-
uals. As such, and unlike probabilis-
tic estimates of population ances-
try, matches among haploid genetic
markers are intuitively easy to under-
stand: an exact match of a male’s
Y chromosome haplotype to a man
living in Australia implies that these
two men share a common paternal
ancestor.
An important issue with regard to
lineage-based genetic estimates is
that they reﬂect only a fraction of
any person’s total genetic ancestry.
For example, the Parsis have Y chro-
mosome information that indicates
an origin in Iran, consistent with the
historical record, whereas the mtDNA
originates in Gujarat, a region in
northwestern India where the Parsis
arrived in approximately 900 AD,
before moving eventually to Mumbai,
India, and Karachi, Pakistan.48,49 This
asymmetry of maternal and paternal
ancestry is not a matter of test incon-
sistency; rather, it reﬂects the high
likelihood that nearly everyone will
have ancestors from different geo-
graphic locations.
Another problem related to lineage-
based comparisons involves the inter-
pretation of exact genetic matches
between individuals. Although it is
biologically justiﬁed to infer that two
individuals with the same mtDNA
haplotype share a common ancestor,
moving from this inference of com-
mon ancestry to the conclusion that
the match implies something about
the biogeographical ancestry of both
individuals can be problematic. For
example, if someone lives in North
America and his or her mtDNA haplo-
type exactly matches an individual
living in Indonesia, the only thing666 The American Journal of Human Geneticsthat can be inferred with conﬁdence
is that they share a common ancestor.
Without more information about
family history and/or the geographic
distribution of closely related mtDNA
haplotypes, it is impossible to say
whether this match arises via recent
Indonesian ancestors in the North
American’s family tree, whether both
share distant ancestors who lived in
an entirely different part of the world,
or whether the Indonesian match has
recent North American heritage. Simi-
larly, it is difﬁcult to arrive at a robust
interpretation of an mtDNA haplo-
type that exactly matches those
sampled from multiple geographic
locations, e.g., Indonesia, Thailand,
and Papua New Guinea.
Autosomal Variants
In comparison to mtDNA and Y chro-
mosome markers, autosomal markers
provide much more comprehensive
information on individual ancestry
because cumulatively they represent
a much greater proportion of genome
history (i.e., multiple biparentally in-
herited loci versus a single locus, as
inherited through mtDNA or the Y
chromosome). However, because the
genome is ﬁnite, only a small fraction
of ancestors are represented by each
given genomic segment in an indi-
vidual, and every ancestor does not
necessarily pass on his or her DNA
at any given genomic segment to a
descendant, so one can only ever
have limited information on the ori-
gins of a given individual’s ances-
tors.10
Autosomal variation can be mea-
sured by whole-genome sequencing
approaches, with genome-wide geno-
typing panels, or via an assessment
of AIMs. Whole-genome sequencing,
although ideal and likely to usher in
a renaissance in genetic anthropology,
is still prohibitively expensive and so
is beyond the reach of most academic
researchers or commercial testing
companies. Genome-wide genotyp-
ing arrays, the next-most comprehen-
sive approach, include SNPs that are
common in a select subset of popula-
tions and lead to ascertainment biases
that can impact ancestry estima-
tion.50 AIMs, most often developed86, 661–673, May 14, 2010to estimate admixture proportions
originating from African, European,
Asian, and Native American popula-
tions,51 offer increased power for
ancestry inference in comparison to
a random set of autosomal markers.
Accordingly, a smaller set of markers
can be used, reducing genotyping
costs and increasing throughput.
The use of AIMs has facilitated
efforts to control for admixture and
population stratiﬁcation in genetic
association studies. Speciﬁcally, know-
ing the proportion of an individual’s
ancestry that originated in different
populations and to what degree a
group is divided into genetic subpopu-
lations can be useful for both reducing
false-positive associations and uncov-
ering true associations. We note, how-
ever, that not all people from a given
population have the AIM(s) identiﬁed
with that population, and people
from different populations can have
the same AIM(s). Gene mapping with
AIMs, or admixture mapping, has
also been used successfully for identi-
fying genomic regions associated
with diseases and health-related traits
such as prostate cancer (MIM
#176807), hypertension (EHT [MIM
#145500]), and white blood cell
count.29,52–54 Admixture mapping is
most effective for identifying genetic
variants associated with health condi-
tions that differ between recently
admixed populations (e.g., tropical
African and European in the case of
most African Americans; and Native
American, European, and African pop-
ulations in the case of Hispanic Amer-
icans) and for which this difference
has not yet been fully explained by
nongenetic factors. Although most
DTC tests for ancestry offer lineage
testing that uses mtDNA and Y-chro-
mosome markers, DTC testing with
autosomal markers, especially with
whole-genomeSNP chips, is becoming
more common. The results reported to
the consumer typically estimate
admixture proportions from several
populations, most often Africans,
Europeans, Asians, and Native Ameri-
cans. However, the interpretation of
such estimates by both the scientist
and the consumer is unclear.
Accuracy of Ancestry Inferences
Ideally, any quantitative claims about
ancestry should have an easily inter-
preted assessment of conﬁdence or
accuracy associated with them. Our
interest in accuracy is to assess not
only what the accuracy estimate is
but also how well we can describe our
conﬁdence in the inferences. We also
stress the difference between accuracy
of a particular individual’s ancestry
versus the inference of ancestry of a
population sample. The former is
particularly important in the case of
DTC ancestry testing, whereas most
scientiﬁc research on ancestry infer-
encedealswith the latter. The accuracy
of ancestry inference methods is a
function of (1) how the underlying
patterns of human genetic variation
are distributed across the geographic
range of human habitation, (2) how
that diversity is surveyed (i.e., the
type and number of genetic markers
used) andwhowas sampled, (3) which
populations are used as references, and
(4) the statistical methods used for
interpreting patterns of variation.
Distribution of Genetic Variation
Accuracy is limited by the fact that
every person has hundreds of ances-
tors going back even a few centuries
and thousands of ancestors in just
a millennium. There is enormous
stochastic variation to the portion of
the genome retained in a descendant
from a given ancestor, and there is
a rough expectation that it halves
every generation. Genetic ancestry
tests can access only a fraction of
these ancestral contributions. Further-
more, the genomic segments contrib-
uted by a particular ancestor are far
from all being uniquely identiﬁable,
so even if one’s genome has those
speciﬁc contributions, identiﬁcation
of particular ancestry is always uncer-
tain and statistical.
Geneticists also make speciﬁc
choices about which levels of ancestry
to examine. For example, many esti-
mations of genetic ancestry are de-
signed to distinguish contributions
from reference populations that live
in particular geographic regions (e.g.,
West Africa, Europe, East Asia, and
the Americas) that were prominentin colonial-era population move-
ments. This creates a bias that might
lead us to deﬁne ancestry in reference
to particular sociopolitical groups.
Moreover, our knowledge of diversity,
and hence the genetic contributions
to ancestry, of populations in many
other parts of the world (e.g., East
Africa, South Asia, Arabian Peninsula,
and Southeast Asia) is limited.
Lineage Identification with Uniparental
Markers
While it is now possible to identify
related groups of Y-chromosome and
mtDNA lineages with high accuracy,
population-level inferences that have
been made from these uniparental
systems are substantially less accurate.
Two simple examples help to illustrate
this point. A large number of single-
site changes have served as the basis
for breaking Y chromosomes into
different ‘‘haplogroups,’’ and it is
accurate to say that Y chromosomes
within, say, haplogroup C are more
closely related to one another than
to a Y chromosome from haplogroup
J. Thus, if two men both carry hap-
logroup C Y chromosomes, they are
more likely to share a paternal lineage
than if they had different haplo-
groups. Even so, this relationship
does not mean that they are more
genetically similar overall.
On the other hand, in the scientiﬁc
literature there has been a connection
drawn between one subset of hap-
logroup C and Ghengis Khan on the
basis of the commonness of that
branch of the Y chromosome gene-
alogy in parts of the world conquered
by Ghengis Khan.55 Although such a
connection is by nomeans impossible,
we currently have no way of assessing
howmuch conﬁdence to place in such
a connection.We emphasize, however,
that whenever formal inferences about
population history have been attemp-
tedwithuniparental systems, the statis-
tical power is generally low. Claims of
connections, therefore, between spe-
ciﬁc uniparental lineages and historical
ﬁgures or historical migrations of
peoples are merely speculative.
Admixture Estimation
For autosomal markers, ancestry infer-
ence is most often performed underThe American Journal of Humana discrete-deme admixture model
where there is a set of discrete demes
(usually or always referred to as
‘‘ancestral’’ or ‘‘parental’’ popula-
tions), and each individual inherits
proportions of his or her genome
from each of these demes. The goal
of the method is to estimate this list
of admixture proportions for each indi-
vidual. Strictly speaking, a deme is a
breeding population, deﬁned on the
basis of population genetic inference
of intermixed genetic variation, and
it is unlike classical anthropology’s
‘‘races,’’ which are deﬁned by mor-
phology.11 Nonetheless, the emphasis
of admixture estimation on differ-
ences over similarities can be mis-
leading about the overall genetic
structure of the human species.
Admixture estimation has greatly
advanced the ﬁeld of ancestry infer-
ence; however, there are caveats to
the interpretation of its results. First,
the ‘‘ancestral populations’’ are not
directly observed—although in many
applications, samples from related
populations are used as a proxy. For
example, present-day Yoruba are
the most frequently used proxy for
inferring African American ancestry,
despite the fact that most African
Americans derive their ancestry from
diverse West African (and other
African) populations that existed
over a span of several centuries and
that might not all be well represented
by present-day proxy popula-
tions.46,56,57 Second, if some ancestral
populations are missing altogether
from the analyses, programs such as
STRUCTURE58 and FRAPPE59 will
force the results into a composite of
the reference samples used; therefore,
the results will be skewed simply
because of how the algorithms work.
If a poor proxy is used for one ances-
tral population, the method might
compensate by adding admixture
from other ancestral populations.
Consider genetic ancestry testing per-
formed on an individual we will call
Joe, whose eight great-grandparents
were from southern Europe. The
HapMap populations are used as refer-
ences for testing Joe’s genetic ancestry.
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consist of ‘‘northern’’ Europeans. In
regions of Joe’s genome that vary
between northern and southern Eu-
rope (such regions might include the
lactase gene, LCT [MIM #603202]),
the genetic ancestry test using the
HapMap reference populations is
likely to incorrectly assign the ancestry
of that portionof the genome to anon-
European population because that
genomic region will appear to be
more similar to the HapMap’s Yoruba
or Han samples than to its (northern)
European samples.
Although the discrete-deme admix-
ture method is informative about
ancestry in settings where individuals
have recent admixture from diverse
continental populations, it does not
performwell in settingswhere individ-
uals have more ancestors from across
a continuous gradient of genetic
diversity. European populations, for
example, despite revealing genetic
differences, have been shown (as
described above) to exhibit mainly
continuous spatial patterns of varia-
tion. When admixture is estimated
for European individuals under the
assumption of two ancestral popula-
tions,28 the method chooses admix-
ture proportions that make individ-
uals a mixture of ‘‘northern’’ and
‘‘southern’’ ancestral populations
even though there is no independent
evidence that two such ancestral pop-
ulations ever existed.
Methods for addressing continuous,
spatial population structure are still
under development, but principal-
components analysis (PCA) has been
widely applied in this context.60,61
The expected behavior of PCA on
evenly spaced samples from spatially
structured data is to return coordi-
nates that are related to the geo-
graphic origin of each individual.62
Moreover, there is a clearly established
relationship between the genealogical
structure of a sample and the principal
components, grounding PCA in ﬁrm
principles of population genetics.63
One caveat of PCA-based approaches
is that if individuals are a product of
‘‘recent admixture’’ from disparate
origins, it will assign individuals to a
single origin that is intermediate668 The American Journal of Human Geneticsbetween the source populations,
which is incorrect (e.g., an individual
with an East Asian and European
parent will be indistinguishable from
an individual from Central Asia).
This reinforces the need for models
that take these and other limiting
factors into account and recognize
that in some cases accurate social
identiﬁcations cannot be made.
Reference Samples
To infer ancestry, researchers rely on
comparing any individual’s particular
genetic proﬁle to that of reference
populations. Research geneticists ben-
eﬁt from various publicly available
databases such as the HapMap,
Human Genome Diversity Panel, Per-
legen Human Genome Resources,
POPRES project, and Seattle SNPs pro-
jects. However, even the databases
that researchers consider the most
applicable reﬂect a woefully incom-
plete sampling of human genetic
diversity, and this has important con-
sequences for the accuracy of ancestry
inference. One problem is that the
‘‘ancestral populations’’ assumed by
some methods are not explicitly rep-
resented in databases—and indeed
cannot be represented as such because
we do not have the ability to sample
ancestral populations. A second
problem is that populations that are
mixtures of the ‘‘typical’’ reference
populations (e.g., Africans, Asians,
and Europeans) are substantially
under-represented in these databases.
Recent sampling efforts, such as
HapMap Phase III samples, are help-
ing to remedy this problem; however,
continued attention to diverse sam-
pling will be an important aspect of
any subsequent surveys of human
genetic variation.
Some commercial scientists and
private groups have their own unpub-
lished databases with the potential
to provide more reﬁned information
than that available from publicly
available resources. In some cases,
the commercial interest in ancestry
testing is indirectly beneﬁting public
research. For example, the company
23andMe partially funded the geno-
typing for the Human Genome Diver-
sity Project samples.38 Although such86, 661–673, May 14, 2010collaborations might be helpful and
commendable, vigilance is needed in
identifying and addressing potential
conﬂicts of interest. The scientiﬁc
claims of companies that choose not
to disclose the contents of their pro-
prietary databases cannot be assessed;
therefore, the reliability of the infor-
mation they provide to consumers
cannot be veriﬁed.64
Statistical Methods
Regardless of the methods used or
samples referenced, steps should be
taken to adequately convey the
amount of uncertainty in the infer-
ences about ancestry, whether in the
research or commercial setting. Popu-
lation genetic inference is ultimately
a statistical exercise, and rarely can
deﬁnitive conclusions about ancestry
be made beyond the assessment of
whether putative close relatives are
or are not related. Because ancestry
inferences for less simple questions
require reliance on complex statistical
procedures with inherent uncertainty,
both producers and consumers of
genetic ancestry estimates need to
have a fairly sophisticated under-
standing of probability.
There are two levels to the inherent
uncertainty of these statistical infer-
ences. First, there is uncertainty in
parameter estimates (for instance,
how large are the conﬁdence intervals
of admixture coefﬁcients for an indi-
vidual?). Second, there is uncertainty
in how to interpret these parameters
(e.g., what do the admixture coefﬁ-
cients mean—what does an individ-
ual’s haplogroup say about his or her
past?). The context in which ancestry
estimation is being used determines
the importance of these sources of
error. In some research contexts (e.g.,
when ancestry is used as a covariate in
genome-wide association studies), it
might be sufﬁcient to have some
quantitative variable that represents
ancestry. In commercial ancestry-
testing applications, however, inter-
pretationoften iskeybecause the infor-
mation that is presented might have
direct psychosocial and other personal
implications for the individual.
The statistical methods used to
perform ancestry inference vary with
regard to the assumptions they make,
how much of the information avail-
able in the genetic data is extracted,
and how their statements about infer-
ence are summarized for the re-
searcher or the consumer receiving
the information. The ease in under-
standing the statistical conﬁdence in
the ancestry inference also varies
widely among methods. The most
important aspect of reporting conﬁ-
dence in ancestry determinations is
to accurately convey the level of un-
certainty in the interpretations and
to convey the real meaning of that
uncertainty.
Ancestry and Health
(Note: unlike in other sections of this
report, where we mention ‘‘race’’ to
make speciﬁc points, in this section
we use ‘‘race’’ (and ethnicity) as con-
structed by the US Ofﬁce of Manage-
ment and Budget (OMB) and as used
in US social, government, and bio-
medical research parlance. We realize
that there are various connotations
and limitations of these terms, but
our goal here is only to provide a brief
overview of some important issues
pertaining to health outcomes and
health differences within and among
the referent ancestry-linked sociopo-
litical groups.)
Researchers still poorly understand
the relationship of genetic ancestry
to individual and population health,
but this relationship is a potentially
important area for investigation in
that it might have social and politi-
cal consequences.65–68 In the US, it
has been commonplace to report
disease prevalence for each racial or
ethnic group separately, and these
prevalence estimates often vary
among groups.69 This has led to wide-
spread speculation that racial or
ethnic differences in individual or
population health are primarily due
to genetic factors, including genetic
ancestry.68,70 Yet, racial or ethnic
identity could be associated with the
health of an individual or group in
several ways. It might co-vary with
different environmental or genetic
factors that underlie risk or with
different interactions within andbetween genetic and environmental
factors.71–73
There are circumstances in which
genetic factors inﬂuencing heath-
related traits are associated with
speciﬁc genetic variations that tend
to be more prevalent in a particular
racial or ethnic group than in the
rest of the population. Certain genetic
variants associated with hyperten-
sion,52 type 2 diabetes mellitus (T2D
[MIM #125853]),74 end-stage renal
disease (FSGS4 [MIM #612551]),75,76
prostate cancer,53,77 and some treat-
ment responses 78,79 have been shown
to differ signiﬁcantly in frequency
among groups. Therefore, disease risk
or treatment response is associated
with and, in some situations, inﬂu-
enced by genetic factors that vary
among racial or ethnic groups. It is
not clear how much of this is actually
gene expression versus DNA
sequence.
Given the complexity and limited
understanding of the relationships
among genetic variation, ancestry,
race, ethnicity, and health and treat-
ment outcomes, the translation of
genetic epidemiological research ﬁnd-
ings to clinical application requires
ample consideration of a variety of
factors, including personal, social,
and other nongenetic factors. This
issue might be highlighted in the
context of DTC genetic testing, where
consumers might share ancestry test
results or ancestry-related estimates
of disease risk with their healthcare
providers and expect that the informa-
tion be factored into their care.3,68 In
view of the ongoing national efforts
to increase the public’s exploration of
family (health) history,80 it is possible
that this practice could become wide-
spread as people seek to exhaust the
available sources of information about
their family history and associated
health risks. As such, the healthcare
community must be recognized as a
key stakeholder in decision making
concerning genetic ancestry infer-
ence.
Personal and Societal Implications
Ancestry inference—in both its re-
search and commercial applications—The American Journal of Humanprompts a host of psychological,
social, legal, political, and ethical con-
cerns from the individual to the global
level. These actual or potential conse-
quences have received increasing
attention3,6,81–86 and must be consid-
ered alongside relevant technical and
analytical issues.
Knowledge about genetic ancestry,
particularly if undesirable and unex-
pected, can lead to the reshaping of
group, familial, or personal iden-
tity.87–91 Anthropological and popula-
tion-genetics research that postulates
or casts doubt on ancestral relation-
ships has historically incited varying
degrees of identity-related conﬂict.
Some of the most notable examples
include the case of Kennewick Man,92
research linking the Lemba and certain
Jews,93,94 and the discovery of family
ties between Thomas Jefferson and
Sally Hemings.95 The occurrence of, or
potential for, emotional distress in
people, families, and groups after
receipt of conﬂicting information
about their identity through DTC
ancestry testing has also been dis-
cussed.3,15,87,89–91 Nonetheless, some
research focused on consumers of
ancestry testing has revealed that
although ancestry tests might promote
genetic thinking about ancestry and
‘‘race,’’ test takers also were able to
construct meaningful narratives of
their identity.5 Clearly, additional
empirical research will need to
adequately explore the relationship
between genetic ancestry testing and
the identities and overall psychological
well-being of test takers, their families,
and their communities.
Questions have been raised about
privacy and about the security of refer-
ence databases that support ancestry-
estimation endeavors. For example,
for genetic-ancestry-testing compa-
nies that are sold or go bankrupt, there
are concerns about the future of the
privacy policies and other terms under
which data were collected.96 Some
people also fear that commercial
ancestry-testing databases might be
more vulnerable than other genetics
databases to alternate and inappro-
priate uses.64,97 The problem of alter-
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ancestry estimation might also be
extended to the unauthorized inclu-
sion of population-based genetic
research data or samples in ancestry-
related studies6,98 or in commercial
ancestry-testing databases. These
practices bring to the fore consider-
ation about evolving notions of
consent, anonymity, respect for
communities, group risk-beneﬁt
assessment, and beneﬁt sharing, and
these issues must also be addressed
within the current broader discourse
on the sharing and secondary use of
genetic and genomic data and
samples.99,100
A common concern about scientiﬁc
efforts to explain origins is the alleged
diminished regard for important
cultural, religious, social, historical,
and political processes that inform
origin as well as group membership,
identity, and rights.3,16,101 Reports of
the use (or intended use) of ancestry
test results to make claims for beneﬁts
throughafﬁrmative actionor for rights
perceived to be associated with their
new-found Native American status
have increased unease over the loss
or gain of certain rights or entitle-
ments.91,102,103 Entitlement could
also be viewed in terms of interest
among some DTC-ancestry-test takers
in seeking dual citizenship in coun-
tries identiﬁed as their ancestral home-
lands.104 This trend is similar to that
discussed in relation to some popula-
tion-genetics research connecting the
Lemba and certain Jews.87,105 It
remains to be seen what tangible
effects (if any) genetic ancestry infer-
ence will have on these pre-existing
entitlement issues.
Genetic ancestry inference (in
particular, the use of AIMs and admix-
ture mapping techniques) could
reveal the nuances of ancestry and
dispel the notion of race in humans
and/or the practice of equating race
with ancestry. Paradoxically, it is
equally capable of giving credence to
the idea that humans subdivide into
distinct biological races and implying
that there are the clear-cut connec-
tions between DNA and speciﬁc
geographic regions or ethnic groups.
There has been substantial anxiety670 The American Journal of Human Geneticsand discussion about the potentially
reifying effects of current ancestry-
estimation practices.3,16,86,106 Beyond
ancestry estimation itself, the routine
treatment, in science, of ancestral,
ethnic, and so-called racial groups as
bounded biological entities perpetu-
ates an inaccurate concept of human
variation and increases the possibility
of stigmatization and discrimination
of the groups and the people within
them on the basis of traits, behaviors,
diseases, and other attributes.64,70,107
Scientists and the scientiﬁc establish-
ment as a whole must attend to this
longstanding and pervasive problem
of conveying conﬂicting messages
pertaining to human variation.
Although genetic ancestry infer-
ence in research and the marketplace
is the focus of this report, we are well
aware that the technologies are being
employed in other arenas. For ex-
ample, since 2003, the forensic use
of DNA tomake determinations about
ancestry in criminal cases has become
more widespread.107–110 More re-
cently, the ‘‘Human Provenance pilot
project’’ proposed using DNA ancestry
testing to identify the nationalities
of people seeking asylum in the
UK.111,112 These and other such appli-
cations of genetic ancestry estimation
also merit scrutiny because they have
the same technical problems dis-
cussed above and may pose palpable
threats to human welfare.
Conclusions and
Recommendations
Concerns about analytical proce-
dures, interpretation, and the per-
sonal and social implications of ge-
netic ancestry inference make it clear
that enormous care is required in
the application of ancestry estimation
in both research and commercial
settings. A major issue regarding com-
mercial ancestry testing is that there is
no quality assurance guarantee. This
gives rise to the question of whether
there is a need for lab certiﬁcation or
accreditation. We tend to lean against
anything so formal because it would
provide a stamp of approval by any
designated accrediting body. It is one
thing to certify accuracy of the geno-86, 661–673, May 14, 2010typing procedures, but it might not
be very useful to do that and also
claim that the inferences from the
data are not validated or certiﬁed in
any way. Determination of feasibility
or of mechanisms for certiﬁcation
and validation, as well as speciﬁc
approaches for enhancing consumer
understanding of the scientiﬁc and
nonscientiﬁc issues, will require
thoughtful deliberation beyond the
scope of work of this task force.
The academic research community
cannot afford to be exempt from
similar efforts to increase scientiﬁc
rigor and overall accountability in
genetic ancestry estimation. Indeed,
the peer-review processes for funding
and journal publications are designed
to assist in such efforts, but their
effectiveness is compromised by the
inadequacy and inconsistent applica-
tion of existing guidelines in this
area. Because of the intrinsic uncer-
tainties of the science and the poten-
tial societal ramiﬁcations, the ﬁeld of
population genetics as a whole could
beneﬁt from improved and enforced
standards with respect to terminology
and methodologies, as well as inter-
pretation and communication of
research ﬁndings.
Recently, Lee and colleagues6 called
for federal regulation of genetic
ancestry testing. At this juncture, we
offer an alternate approach, one that
might itself lead to federal oversight,
if subsequently deemed appropriate,
necessary, or practical. We believe
that effective decision making re-
garding genetic ancestry inference,
in particular DTC genetic ancestry
testing, will be best initiated through
cooperative interaction among a va-
riety of stakeholders, including suit-
able federal agencies. Considering
that such collective engagement has
not yet occurred, it is premature to
assume reticence or resistance on the
part of any of the players or that
federal regulation is the only recourse.
On the basis of our review of the
state of the science and the personal,
societal, and health-related implica-
tions of genetic ancestry inference in
academia and industry, we make the
following recommendations:
(1) Leadership of the human-genetics
community, diverse in its interests
and its own identities, should
develop mechanisms for pro-
moting thoughtful and rigorous
use of genetic ancestry estimation
in academic research. This might
be implemented throughwork-
shops or similar activities to (a)
identify criteria for appropriate
selection of ancestry-estima-
tion methods and genetic
markers, (b) establish standards
for the representation of the
statistical conﬁdence in an-
cestry inference results, (c)
create guidelines for termi-
nology and the assessment of
methodology in peer-reviewed
research proposals and publica-
tions, and (d) devise strategies
for the effective translation of
ancestry-mediated research
ﬁndings to the general public.
(2) Interested scientiﬁc and scholarly
societies should collaborate to
convene a national roundtable
discussion ofDTCgenetic ancestry
testing. The goal of this face-
to-face conversation among an-
cestry-testing companies and
promoters, consumers, com-
munity leaders, advocacy and
interest groups, geneticists,
social and behavioral scientists,
humanists, healthcare pro-
viders, legal professionals,
federal agencies, media, and
other key stakeholders should
be to identify major issues of
concern and brainstorm prac-
tical solutions. Points for
consideration must encompass
accuracy and the reporting of
statistical conﬁdence, proprie-
tary databases, additional
research, communication of
limitations andpotential conse-
quences, public and personal
education, interdisciplinary
collaboration, andmechanisms
for accountability. Findings
from this meeting will inform
decisions about the next steps.
These interconnected recommen-
dations are intended to foster directand productive dialog surrounding
genetic ancestry inference in aca-
demia and industry and move us
closer to achieving themost beneﬁcial
outcomes for both science and
society. In light of the issues at stake
and the enduring fruitless attempts
at effecting meaningful change, the
time is now for no-holds-barred dis-
cussions among the players, particu-
larly among scientists who must
more purposefully and constructively
critique one another’s premises,
methodologies, ﬁndings, and inter-
pretations of ﬁndings.
Although there might be general
agreement that genetic variation pro-
vides a window into human origins,
history, interrelation, and identity,
differences of opinion about genetic
ancestry inference will probably
persist. Our desire is that, ongoing
conversation and collaboration across
disciplines and sectors will address
principal concerns and reduce the
intensityof thedebate.Anever-present
challenge and responsibility for scien-
tists engaged in this work is to under-
stand the inherent uncertainties, so-
cio-historical contexts, and potential
ramiﬁcations of the science and to
effectively incorporate this knowledge
into efforts to reﬁne their methodolo-
gies and improve human well-being.
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